Is Cerebrolysin FDA approved?

Cerebrolysin is investigational and not FDA approved. It is discussed for research and educational purposes only, not as medical guidance.

Is Noopept FDA approved?

Noopept is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Cerebrolysin administered in research settings?

In research settings, Cerebrolysin is typically administered via the intravenous or intramuscular routes. PeptideBase does not provide dosing or administration instructions.

How is Noopept administered in research settings?

In research settings, Noopept is typically administered via the oral, sublingual, or intranasal routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cerebrolysin vs Noopept

Peptide Comparison

Cerebrolysin vs Noopept

Name: Cerebrolysin vs Noopept — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Neuro & Cognitive peptides.

Cerebrolysin

FPF 1070

CognitiveInvestigationalResearch Only

Half-life: Varies by component

33 providers listed

Full Cerebrolysin profile →

Noopept

N-phenylacetyl-L-prolylglycine ethyl ester

CognitiveNot EvaluatedResearch Only

Half-life: ~15-30 minutes (active metabolite has longer CNS retention)

5 providers listed

Full Noopept profile →

Bottom line

Cerebrolysin carries stronger published evidence (Meta-analysis, 5 key studies) than Noopept (Animal, 1); both are research compounds.

Quick Verdict

Cerebrolysin

Half-life

Varies by component

Noopept

Half-life

~15-30 minutes (active metabolite has longer CNS retention)

Which One Should You Choose?

Your goal	Better option
Stronger clinical evidence	Cerebrolysin
Further along in FDA review	Cerebrolysin
Oral administration option	Noopept
More provider options (33 vs 5)	Cerebrolysin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cerebrolysin

Noopept

Mechanism Family

Neuro & Cognitive

Half-life

Varies by component

~15-30 minutes (active metabolite has longer CNS retention)

FDA Status

investigational

not evaluated

Admin Routes

intravenous, intramuscular

oral, sublingual, intranasal

Availability

Research Only

Providers

33 listed

5 listed

Avail. Notes

Neuropeptide mixture approved in EU/Asia but NOT FDA-approved. Phase 2/3 US trials for Alzheimer's disease and stroke with active IND. No NDA filed. Research use in US.

Russian cognitive enhancer (omberacetam). Prescription drug in Russia. NOT FDA-approved. Sold as nootropic supplement in US but does not qualify as dietary supplement under DSHEA. Unscheduled.

Research Evidence

Cerebrolysin

Meta-analysis · 5 key studies · most recent 2026

Noopept

Animal · 1 key study · most recent 2022

Research Citations

Cerebrolysin

Meta-analysis2019 · Cochrane Database of Systematic Reviews

Cerebrolysin for vascular dementia

Cohort2026 · Asian J Neurosurg

Neuroprotective Effects of Cerebrolysin in Moderate Traumatic Brain Injury with Nonoperative Lesions: A 6-Mon…

RCT2024 · Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Cerebrolysin in the preventive therapy of dementia in elderly patients with mild cognitive impairment: a thre…

In vitro2026 · Cells

Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothel…

+1 more

Noopept

Animal2022 · Neuroscience Letters

Effect of nootropic dipeptide noopept on CA1 pyramidal neurons involves α7AChRs on interneurons in hippocampa…

About Cerebrolysin

Standardized mixture of neuropeptides derived from porcine brain proteins; mimics endogenous neurotrophic factors (BDNF, NGF, CNTF); promotes neurogenesis and synaptic plasticity

Research Areas

neuroprotectionneuroplasticitymemory improvementcognitive recovery

About Noopept

Prodrug converting to cycloprolylglycine; modulates AMPA and NMDA receptors; increases NGF and BDNF expression

Research Areas

memory consolidationlearning enhancementneuroprotectionBDNF increase

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cerebrolysin

Reported (Unverified — Pending Clinical Review)

epilepsyrenal failureporcine protein allergy

No established clinical contraindications

Noopept

Reported (Unverified — Pending Clinical Review)

severe liver diseaseirritability at high doses

No established clinical contraindications

Price (per mg)

Cerebrolysin

$0.83/mg

$0.82 – $0.83 range

9 vendors

View price index →Find providers →

Noopept

Not enough vendor pricing yet.

Find Providers

Where to source these peptides

Providers offering

Cerebrolysin

33 listed

Browse directory →

Providers offering

Noopept

5 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated August 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cerebrolysin vs Noopept — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/cerebrolysin/noopept

https://peptidebase.io/peptides/compare/cerebrolysin/noopept Methodology License Download JSON Download CSV